Category Archives: LABD

In The Spotlight

October 16, 2021 By in Biotech, GDX, LABD, Positions, SPBIO

Beginning Of The End ?

Or … Just The End Of The Beginning ?

Maybe, it turns out that some people don’t want to be in the spotlight after all.

Click on the link.

See if your jaw doesn’t drop with how casually the interview discusses things we (the serfs) should not know.

That interview (at least the ‘tweet’) is from February, this year. So, maybe this is old news to some.

Even so, it’s just one of the many bricks in the wall for biotech.

With that said, let’s take a look at our chief cook and bottle washer: SPBIO

SPBIO (and inverse, LABD) Analysis:

The last update said that we expected SPBIO, to decline and LABD, to rise from current levels.

That’s exactly what happened.

As usual, we’ll start with the unmarked chart:

Obviously, biotech’s not moving higher.

At Friday’s close, it’s down – 28.4%, from the all time highs posted February, this year.

Market Insight:

The ‘tweet’ in the link above, is dated February 9th, 2021.

The all time high for biotech SPBIO, was the very same day: February 9th, 2021.

Remember, there are no coincidences.

Let’s mark up the daily chart; showing that Friday was an outside-down (key reversal) day.

The right-most area of the chart has been zoomed-in.

Higher high, lower low and lower close:

The next chart is where it gets interesting.

We’ve included a Fibonacci projection; going from all time highs to lows in May and then counter-trend high on June 28th:

It’s clear the 23.6%, projection level has been an axis line.

SPBIO, price action has oscillated about this area for months.

With Thursday’s ‘a-b-c’ corrective move and Friday’s outside-down reversal, that axis oscillation may be complete.

If SPBIO is to head lower from this point (which is expected), we’ll watch to see if price action ‘respects’ the Fibonacci projections; that is, will price action head lower to 38%, then 50%, and on?

Positioning:

Friday was a good day to be short via LABD (not advice, not a recommendation).

Biotech, is nowhere near all time highs. The sector is essentially running neck-and-neck with GDX, to the downside.

The expectation’s for SPBIO to head lower in the coming week.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Think, ‘Inside The Box’

October 14, 2021 By in Biotech, GDX, GLD, GOLD, Gold & Silver, Gold Miners, LABD, Positions, SPBIO 7 Comments

Late Session

Or … Who’s In Charge Of The News?

Answer:

The same people who came up with the tag line appearing simultaneously throughout every major corporation:

“We’re all in this together.”

Remember that?

I have an engineering buddy that founded his own muscle car performance company (think “steeroids®”) and he told me the following:

“Once you get out of the corporate world, you won’t be able to think straight for about six months to a year.”

I didn’t quite understand what he meant … that is, until I left the corporate world.

It was just as he said. Six months before the fog began to lift.

Steered To and Fro:

Each corporate directive or news story is out there for a reason. Someone (much higher up) had to decide on its creation and release.

Once out of the box, you can see (if you’re awake) just how much and how deep was/is the control.

What does all that have to do with the markets?

Well, let’s take a look at the latest case of (hyperinflation induced dollar collapse) herd behavior; the gold market.

Gold To Rally?

The gold lunatics are out again … having escaped the asylum yet one more time.

Of course, this upward bounce was predicted well in advance:

Of note: GDX is in ‘spring’ position. An upward attempt is to be expected.

If GDX was to break out and start a sustained bull move, this would be the spot. We’re at the danger point.

Gold and GDX, have indeed put in some kind of a rally. However, let’s see what the gold market (GLD), is saying about itself:

Gold (GLD) Analysis:

As of this post, this is how it looks.

Marking up with a tend-line gets us the following:

On a longer term perspective and if the trendline is broken, we can go back to the original idea of an up-thrust set-up:

As is typical for this site, we’ll let the bulls duke it out with the bears. We’ll wait and see if we’re at a reversal point (trend-line) or if we’re headed to up-thrust condition.

If GLD breaks the trend-line, getting back to the 170 – 171, level (up-thrust), imagine the hysteria. 🙂

Lastly, Biotech (LABD):

First: Did we exit LABD?

Answer is No (not advice, not a recommendation)

Second: Why?

The price action thrusts below support that have been reported in prior posts were indeed spring set-ups.

However, it’s obvious now, they were not THE set-up.

The chart shows LABD has met an ‘a-b-c’ measured move target.

The idealized form of an ‘a-b-c’ corrective move, is shown with the blue lines and notations:

At this juncture, wave ‘a’ net distance traveled, is equal to ‘c’ and wave ‘b’ net distance, is about 50% the length of wave ‘a’.

These measurements are typical for ‘a-b-c’.

Positioning:

My firm’s main position is still showing a good profit and we’re going to maintain short biotech via LABD (not advice, not a recommendation).

However, as with GDX being at the danger point before its rally, so too is biotech at the danger point (prior to a potential decline).

Expectations are for LABD to retrace higher from current levels.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech: The Thrust Is Gone

October 13, 2021 By in Biotech, LABD, SPBIO

Before The Open

Biotech SPBIO And Inverse LABD:

Ready To Reverse.

We’re using the leveraged inverse fund LABD, for our analysis (SPBIO down, LABD up).

Yesterday, closed with the 4-Hour chart above.

Annotating with Force Index numbers; each early session 4-Hour bar for the past two days, has been posted on decreasing downward thrust (last two magenta down-arrows).

In addition, the first four hours of the last session penetrated support and then retraced in the next four hours (last bar).

That sets up a spring condition as shown:

Taking Forever?

If this really is the crest of a major (overall market) reversal, we need to remind ourselves, it’s a massive juggernaut.

Said many times, we (my firm) are looking and working on the big move (not advice, not a recommendation).

By definition, it’s not a popular method.

Nothing seems to be happening … until it does. Then, it’s too late to position.

Pre-Market:

With about 17-minutes to go before the open, LABD is trading unchanged.

Obviously, the first four hours of trade will be important.

The market (LABD) could continue to grind lower … or we may be at the end of the counter-trend move; ready to reverse upward for LABD and down for SPBIO.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Hidden In Plain Sight

October 11, 2021 By in Biotech, I Allegedly, LABD, Positions, SPBIO

Mid Session:

The best way to hide something, is to put it out there for all to see:

In plain sight

However, for the oligarch’s target audience, the proletariat, they can’t actually ‘see’. It’s all by design.

They’re hypnotized, programmed, demoralized; just doing and not thinking.

Which home improvement center has the tag line played over and over through their speaker system (paraphrasing) ‘doers getting things done’.

If you think about it, ‘Doers’ don’t think. They just ‘do’. A perfectly controllable, mindless herd.

Going one step further, is to have these proles so mentally damaged, they actually think, there’re thinking.

Which brings us to our chief cook and bottle washer for the day: Southwest Airlines

Southwest Cancels Flights:

The official company line is cancellations were due to weather which is obviously not true.

This report from KHOU in Houston, says the cancellations were about something else. It’s in the title but that’s not what the news story’s really about.

Go ahead and watch. Stop the video after thirty seconds and tell me (figuratively) what’s the real intent.

If you can ‘see’, it’ll be obvious.

Actually, this was an easy one.

This news story has nothing to do with cancellations and everything to do with ‘compliance.’

Present the image over and over of compliance (masks) and then it takes on a life of its own.

For example, we can see that type of compliance in this Facebook post (at left) put out in my area just yesterday.

It’s not hard to surmise (and tragically, so) there’s probably not going to be a ‘Second Year’ photo shoot.

This Is Now:

I have family members that essentially fall into two camps:

The first, plugs their ears and chant “la, la, la, it’s not happening”.

The other camp mumbles over and over (for years now) “it shouldn’t be this way”.

Neither camp has, is, or will do anything to get ready.

Icing on the cake is the typical response of, ‘Your information’s not from a reputable source’.

What, like Fox News?

You may, and probably do have similar stories.

In line with it’s not happening, or the government should fix it so it won’t be this way, we have Dan from I Allegedly.

He just posted another update. At time stamp 20:20, people are still expecting a fourth stimulus check.

That’s something else that’s not happening.

Which all brings us to what really is happening … our second topic of the day: Biotech

Biotech SPBIO (LABD) Analysis:

It’s been an up day for biotech (down for LABD) thus far but that’s not the real story.

The chart below is from earlier in the session. We’re looking at the leveraged inverse fund LABD, on the hourly basis:

Next, we have our ‘usual suspects’ mark-up showing us the potential opportunity:

From a personal standpoint, being short biotech via LABD (not advice, not a recommendation) has been tiring.

Especially on days like today.

You can watch your main account fluctuate (in the red) by what used to be, in the corporate world, two to four week’s pay; all happening in a single hour.

However, even as this post is being created, we now have LABD posting the following:

Upside action off the spring looks strong. However, there could still be a downward test.

SPBIO, Last Chance?:

Intuitively, this could be it for biotech (SPBIO) to the upside.

The reason for that conclusion is:

If the spring set up holds with sustained upward action in LABD, it sets up a potential measured move condition (not shown); targeting LABD to much higher levels.

In that case, SPBIO would move lower … much lower and possibly well past any nearby major support.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech Retrace

October 7, 2021 By in Biotech, LABD, Positions, SPBIO

Mid Session

Putting It In Perspective

Biotech (SPBIO) is still well off the highs and in bear market (below 20%) territory.

We’re going to take the last section of the chart, highlighted below and expand it out to hourly.

Hourly detail is below:

There was a minor penetration of support yesterday, the 6th; that has resulted in a spring condition upward move.

Now, we’re at the Fibonacci 23.6%, retrace of the down-move that started on September 2nd.

Spring-To-Up-Thrust ?

Looking at the hourly, it’s clear just a little farther up and we’ll penetrate minor resistance (which is also the 23.6%, retrace). Doing so, would put price action in the all too familiar and well documented ‘spring to up-thrust’ condition.

At mid-session, with SPBIO retreating (slightly) from the highs, it may not make it to up-thrust, today.

However, one still needs to be aware of the possibility.

Positioning:

As my firm is positioned short this sector (not advice, not a recommendation), being in the red for the day is never fun.

However, at this juncture, the charts themselves say there’s nothing untoward about maintaining short.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech, Trending Lower

October 6, 2021 By in Biotech, LABD, SPBIO, Wyckoff

Early Session

The Lies And Reality, Don’t Match

You would think with all the announcements about corporations (forcing) their employees to become ‘fully protected’, the biotech sector would be launching higher.

After all, that sector’s about to get a massive increase in revenue as the major players continue on with their ‘protection’ plan.

Just yesterday, late in the day was this announcement.

Looks like 1,400 non-compliant, undesirables have been dealt with.

Let’s do some math.

If that was 2% of the workforce, that means just for this employer alone, approximately 68,600 (subtracting 1,400 from 70,000) have now received a ‘bonus’ from the company.

If the scientific (real science) estimates are correct, the ‘elephant‘ will begin to kick in within six months and be fully effective (terminal) within five years.

This example is not the only one … Southwest Airlines just announced a similar push; fully ‘protected’ by the end of the year.

With all this good news, one would expect the biotech sector (SPBIO) to be launching higher in an unstoppable rally.

Um, no.

Let’s take a look at what’s really going on with the price action.

SPBIO (and 3X inverse, LABD):

We’re going to use the 3X inverse SPBIO fund LABD, for our analysis.

We’re about 30-minutes past the open and SPBIO, is heading lower with inverse LABD, moving higher:

We’re going to digress just a bit; updating on the ‘alternating’ action discussed in this update.

Price action above, is choppy and overlapping. That’s different from what we see now:

With all that being said, it’s possible LABD, has just confirmed the right side of a trend-line:

As a reminder, biotech (SPBIO) is the only major index that just finished three down quarters in a row.

If current action continues … it’s on track to make it four.

Wyckoff said it a century ago:

‘Somebody always knows something. That something, is reflected in the tape (price action)’.

The lies and reality don’t match. Biotech is losing steam … possibly in anticipation of an ‘event’ of some kind.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech: Three In A Row

October 1, 2021 By in Biotech, GDX, GDXJ, GLD, Gold & Silver, Gold Miners, I Allegedly, LABD, SPBIO 2 Comments

Early Session

It’s Official:

Down, Three Quarters In A Row

No other major index has three consecutive quarters lower.

Even the gold miners (GDX, GDXJ), while in a bear market, still had an up quarter with the one ending June 30th, this year.

So, what does this mean?

Slow At First. Then, All At Once:

The first answer is the obvious one; the air is slowly but steadily (thus far) coming out of this sector.

The second answer is more complicated.

As discussed yesterday, we’ve seen the phenomenon of instantaneous focus shift in disparate parties … a well documented and repeated occurrence in the animal kingdom.

We could see a similar thing with biotech or the markets overall.

As Dan from I Allegedly reported yesterday, the container ship pile-up off the coast and slow unloading is intentional.

The resulting shortages are intentional.

The corresponding price rises (camouflaged as ‘inflation’ by the media), are intentional.

It’s possible (speculation) that by having prices go up and the media touting it as inflation, the public, pile into the corresponding sectors such as gold, silver and the miners … all of which have been heading lower.

More importantly, what this crowd does NOT do, is go the other direction; sell and sell short, stockpile food, water, medicine, tools, hardware, consumables, protection, backup power.

Of course, some of them are.

However, just in my neighborhood as I look around and down the street, there are fifteen houses that are visible.

I know for a fact, only two (this residence and the neighbor across the street) have been, and are, taking preparatory action: That equates to 13%.

Driving through the neighborhood to get to a main road, there are about another 40 homes.

I can see, none of them have an operation garden (or livestock) of any kind: That makes our ‘prep’ percentage go down to 3.6.%.

The real percentage (for the entire neighborhood) may be close to 0.5%, or less.

This is probably a typical number but your mileage may vary.

Instantaneous Shift:

That low percentage (0.5%), gives a clue to how vicious a down-draft could be once everyone realizes they’ve been had.

Couple that with our ‘elephant’ from yesterday, and it may be absolute insanity.

All of which, brings us to the chart of biotech (SPBIO).

SPBIO Analysis:

Not only was it a down quarter but on a monthly and weekly basis, SPBIO has posted reversal and continuation (down) bars respectively.

The unmarked monthly chart of SPBIO, is below:

The next two charts show monthly reversal bars and then a Fibonacci projection to lower levels.

The projection was taken from the all time high on February 9th, this year, to the intermediate low, May 11th; then the counter-trend pivot high on June 28th.

It’s interesting to note; the monthly reversal bars are Fibonacci 8-months apart.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Elephant In The Room

September 30, 2021 By in Biotech, I Allegedly, Jerimiah Babe, LABD, Positions, Project Stimulus, Texas Silver 16 Comments

Mid Session

… It’s Already Here

Nearly simultaneously, all three YouTube channels that are monitored closely, have shifted their focus.

This phenomenon, instant change among disparate parties, has been well documented in the science community (before that community became corrupt) with animals on separate continents.

In short, it was found that herds of animals would instantly change their behavior to be congruent with each other even though there was no direct visible or physical connection.

It’s sort of a ‘collective consciousness’ phenomenon.

The YouTube presenters being discussed are:

I Allegedly

Jerimiah Babe

Texas Silver

Dan (I Allegedly) has literally thousands upon thousands of contacts. He’s an invaluable source of information.

He also has the stamina to sit through a Fed speech, Senate or Congressional hearings and the like … then report on what’s being discussed.

Jerimiah Babe gives us ‘boots on the ground’ reporting about the economic collapse so that we can see it for ourselves.

Texas Silver has the warrior mentality (and is not some coward ‘poser’ with useless crap all over his AR), showing us a working homestead and all that’s involved.

Their instantaneous shift in direction is being highlighted; not the importance of their channels which remains at the high end.

From a physical standpoint (like the animals separated by continents) they are not physically connected to each other.

Pulling Away From Precious Metals

Yet, all three have pulled away (in varying degrees) from the ‘stacking’ mentality.

Admittedly, Dan was never really a stacker … but he has changed direction; now talking about procuring supplies, food, water, medicines.

Be aware, there may be yet another collective shift (this time, world-wide) on the horizon.

Festering in the background, is an event that won’t be able to be ignored or dismissed as ‘conspiracy’ much longer .

It’s important to get out in front (if you aren’t already) and position oneself accordingly.

Which brings us to the elephant.

Biotech, SPBIO:

That elephant is, we’re at the front end of a potential mass genocide event (that’s already underway).

Conditions are already set in motion for a loss of the world-wide population of at least 5% – 10%, in the next 2, to 5 years (and that’s probably very conservative).

The chief cook and bottle washer in all of this, is biotech.

LABD (3X Inverse SPBIO):

Several charts are below. The vertical scale has been compressed to show the potential of the nascent move:

Today is the last trading day of the third quarter.

SPBIO, is on track to post lower three quarters in a row. No other major index is in the same position.

It seems to be taking forever but the case against biotech continues to build.

Positioning:

No doubt we’re short this sector via LABD (not advice not a recommendation), in a big way.

LABD has apparently finished its downward testing.

Now, as discussed (here and here), price action is alternating to the upside.

With that in mind, the new daily high of yesterday has not yet been reversed. This is alternating action when compared to the daily high reversal of September 20th.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Is The ‘Bounce’, Over?

September 28, 2021 By in Biotech, LABD, S&P, S&P 500, SPY 1 Comment

Early Session

S&P Bullish … Or Bearish?

This is how the S&P (SPY) looked before the open.

The blue lines show a small wedge pattern. Under bullish conditions, price action continues higher into a measured move; somewhere around SPY 449 – 450.

What we got at the open, is below:

The SPY opened lower and so far, has not continued its upward momentum.

It may be nothing; or it may signal the Right Shoulder of the Head & Shoulders, is complete.

As always, anything can happen. SPY may be just gathering steam for an attempt at new daily highs.

However, the action in biotech indicates the bears are moving into the markets; behind the scenes and slowly at first.

Biotech, SPBIO:

Biotech has opened lower (LABD higher).

Yesterday’s price action was entirely consistent with the ‘alternation’ discussed in that update.

For Example:

There was no (immediate) downward test from the September 17th low … and this time, the September 23rd low, there was:

We can see, after the open, price action for LABD is pushing higher (lower for SPBIO):

If we get a new daily high for LABD (above yesterday’s 19.62), it signifies the lower testing action is likely complete; the bears are taking control of biotech.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Rule of Alternation: Biotech

September 27, 2021 By in 1907, Biotech, LABD, Livermore, Positions, Prechter, SPBIO 3 Comments

Early Session

What Happened Last Time … Won’t Happen This Time

We have four more trading days until the end of the Third Quarter. It’s unlikely that biotech (SPBIO) is going to make a new quarterly high.

This morning’s early action has LABD (3X inverse SPBIO) essentially unchanged to slightly lower; higher for SPBIO.

The weekly chart of SPBIO, above, has been inverted to mimic the inverse fund LABD … but without the tracking (bias) errors.

The “tight” area of action has been expanded in the next chart:

We can see the wide, high volume bar from the week of 8/27, is being tested by the subsequent weeks and their upward action.

This is normal market behavior that has probably been repeating itself since the buttonwood tree.

Alternating Action:

The difference this time around, we’ve already had the ‘low to upward thrust’ (for LABD) that was negated last week with a test.

That test has now reversed as seen on the 4-Hour chart (inverted SPBIO) below:

Both downward thrusts (September 17th, and 23rd) finished the day at or near their session lows.

The ‘rule of alternation’, from Prechter’s Elliott Wave discussions, essentially says that; what happened last time, will not happen this time.

That leaves two scenarios for SPBIO and LABD.

Scenario, No. 1

SPBIO reverses from here and goes on to make new daily, weekly highs.

Scenario, No. 2

SPBIO continues its downward reversal into the next leg lower; potentially to the Fibonacci projection target (not shown) of 161.8%.

That would put SPBIO, at or near the 3,873 level … a decline of nearly 62%, from last Friday’s close.

Force Index:

Since the inverse fund LABD is heavily traded (2mil – 3mil, shares per day), we can use it as a good indicator of professional trader commitment

I say ‘professional’ because, as incredible as it may seem, the majority of market participants (the amateurs) do not understand or can’t grasp the concept, the big money is made on the downside.

The trading books that regale stories of massive gains, were typically trades to the downside … probably the most famous of which, was Livermore’s well documented short position during The Panic of 1907.

I’ve even talked to a former broker (for a firm that has 15,000 locations nationwide) who asked me when I was discussing the markets (and I quote): “What’s an inverse fund?”

I kid you not.

As touched on yesterday with Random Notes, the level of complacency, stupidity and ignorance has reached levels that are not going to be repeated in our lifetimes.

Market participants are either going to be wiped-out … or they’re going to get very smart, very fast.

I’m personally going with the ‘wiped-out’ scenario as it’s extremely difficult to come up to speed on a complicated topic (reading price action) while your account is being decimated.

Which brings us to the Force-Index chart of LABD:

This chart’s a little different than the rest.

The Force Index section (the lower panel) has been expanded to show the nuances of thrust action.

Even all the way back to the major thrust lower on August 23rd, we can see, downward thrust energy has been dissipating.

Recently, as shown with the blue arrow, downward thrust has evaporated altogether.

Summary:

It appears from the 4-Hour chart of LABD, we’re potentially at a major point of inflection (not advice, not a recommendation).

The rest of the indices (except the miners) are at or near their all time highs … with valuations (P/E ratios) stretched to the highest on record; going all the way back to 1962, if memory serves.

SPBIO is the only major index that’s about to post three down quarters in a row.

Obviously we’re short this sector via LABD (not advice, not a recommendation) with the understanding that anything can happen.

This market (SPBIO) along with the others could reverse and move to new highs.

However, at this juncture, it looks like the air’s coming out of biotech … slowly, at first.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.